Trial
NCT01009931
Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rutgers, The State University of New Jersey
Collaborators
Rutgers Cancer Institute of New Jersey; National Cancer Institute (NCI); Biosuccess Biotech Co., Ltd.
Condition
Leukemia
Intervention
12-O-tetradecanoylphorbol-13-acetate
Why stopped
Study was terminated early due to lack of experimental medication (supply issues)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-04